GENEDX LLC NPI 1487632998

NPI Details

GENEDX LLC is a clinical medical laboratory in Gaithersburg, MD. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. GENEDX LLC NPI is 1487632998. The provider is registered as an organization entity type and is a single specialty group.
The provider .

The provider's business location address is:

205 & 207 PERRY PKWY
GAITHERSBURG, MD
ZIP 20877-142
Phone: (301) 519-2100
Fax: (201) 421-2010

The provider's authorized official is Kevin Feeley .
The authorized official title is Chief Financial Officer and has the following contact phone number (301) 519-2100.

The CLIA number assigned to this NPI record is 21D0969951 - independent with a certificate type of Certificate of Accreditation.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Test for detecting genes associated with disease, genomic sequence, must include sequence analysis of entire mitochondrial genome (HCPCS:81460)
• Gene analysis (muts homolog 2, colon cancer, nonpolyposis type 1) full sequence analysis (HCPCS:81295)
• Gene analysis (adenomatous polyposis coli), full gene sequence (HCPCS:81201)
• Gene analysis (breast cancer 1 and 2) of full sequence and analysis for duplication or deletion variants (HCPCS:81162)
• Gene analysis (adenomatous polyposis coli), duplication or deletion variants (HCPCS:81203)
• Genome-wide microarray analysis for copy number and single nucleotide polymorphism (snp) variants (HCPCS:81229)
• Test for detecting genes associated with inherited breast cancer-related disorders (HCPCS:81432)
• Test for detecting genes associated with disease, whole mitochondrial genome (HCPCS:81465)
• Gene analysis (calcium voltage-gated channel subunit alpha1 a) of full sequence (HCPCS:81185)
• Gene analysis panel for hereditary disorders of the peripheral nervous system (HCPCS:81448)
• Test for detecting genes (HCPCS:81440)
• Gene analysis (ataxin 2) for abnormal alleles (HCPCS:81179)
• Gene analysis (ataxin 3) for abnormal alleles (HCPCS:81180)
• Gene analysis (cch-type zinc finger nucleic acid binding protein) for abnormal alleles (HCPCS:81187)
• Gene analysis (ataxin 1) for abnormal alleles (HCPCS:81178)
• Gene analysis (ataxin 7) for abnormal alleles (HCPCS:81181)
• Gene analysis (ataxin 8 opposite strand [non-protein coding]) for abnormal alleles (HCPCS:81182)
• Gene analysis (dm1 protein kinase) for abnormal alleles (HCPCS:81234)
• Gene analysis (frataxin) of full sequence (HCPCS:81286)
• Gene analysis (calcium voltage-gated channel subunit alpha1 a) for abnormal alleles (HCPCS:81184)
• Molecular pathology procedure level 6 genetic analysis (HCPCS:81405)
• Molecular pathology procedure level 5 (HCPCS:81404)
• Gene analysis (muts homolog 6 [e coli]) full sequence analysis (HCPCS:81298)
• Gene analysis (fragile x mental retardation) abnormal alleles (HCPCS:81243)
• Gene analysis (retinal disorders), genomic sequence (HCPCS:81434)
• Gene analysis (mutl homolog 1, colon cancer, nonpolyposis type 2) full sequence analysis (HCPCS:81292)
• Gene analysis (mutl homolog 1, colon cancer, nonpolyposis type 2) duplication or deletion variants (HCPCS:81294)
• Gene analysis (partner and localizer of brca2) full sequence analysis (HCPCS:81307)
• Gene analysis (poly[a] binding protein nuclear 1) for abnormal alleles (HCPCS:81312)
• Gene analysis (breast and related cancers), duplication or deletion variants (HCPCS:81433)
• Test for detecting genes associated with intellectual disability, genomic sequence analysis panel, at least 60 genes (HCPCS:81470)
• Test for detecting genes associated with intellectual disability, duplication/deletion gene analysis, at least 60 genes (HCPCS:81471)
• Test for detecting genes associated with colon cancer, genomic sequence analysis panel, at least 10 genes (HCPCS:81435)
• Test for detecting genes associated with colon cancer, duplication/deletion analysis panel, at least 5 genes (HCPCS:81436)
• Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) full sequence analysis (HCPCS:81317)
• Test for detecting exome, sequence analysis (HCPCS:81415)
• Gene analysis (survival of motor neuron 1, telomeric) for dosage/deletion (HCPCS:81329)
• Gene analysis (ccaat/enhancer binding protein [c/ebp], alpha) full gene sequence (HCPCS:81218)
• Gene analysis (peripheral myelin protein 22), duplication or deletion analysis (HCPCS:81324)
• Molecular pathology procedure level 4 (HCPCS:81403)
• Methylation analysis (small nuclear ribonucleoprotein polypeptide n and ubiquitin protein ligase e3a) (HCPCS:81331)
• Gene analysis (tumor protein 53) full sequence analysis (HCPCS:81351)

The enumeration date for this NPI number is 1/4/2006 and was last updated on 3/21/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.